Skip to main content
. 2018 Feb 23;29(5):1280–1285. doi: 10.1093/annonc/mdy074

Figure 1.

Figure 1.

The P-G Algorithm: Guidelines for when the RS assay is most likely to provide useful information for adjuvant chemotherapy decision-making for a breast cancer patient. The original AAMC Model ends at AAMC risk assessment of low, intermediate, or high. AAMC, The Anne Arundel Medical Center; ER, estrogen receptor; P-G, pathologic‐genomic; PR, progesterone receptor.